Cargando…

Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review

BACKGROUND: Graft-versus-host disease (GVHD) is a common fatal complication of hematopoietic stem cell transplantation (HSCT), where steroids are used as a treatment option. However, there are currently no second-line treatments for patients that develop steroid-resistance (SR). Mesenchymal stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying, Hao, Jie, Hu, Zheng, Yang, Yong-Guang, Zhou, Qi, Sun, Liguang, Wu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895864/ https://www.ncbi.nlm.nih.gov/pubmed/35246235 http://dx.doi.org/10.1186/s13287-022-02751-0

Ejemplares similares

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)

Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease
por: Kim, YongHwan, et al.
Publicado: (2018)

Mesenchymal Stem Cell Therapy in the Treatment of Acute and Chronic Graft Versus Host Disease
por: Kebriaei, Partow, et al.
Publicado: (2011)

Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease
por: Lin, Yi, et al.
Publicado: (2011)

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
por: Amorin, Bruna, et al.
Publicado: (2014)

Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
por: Zhou, Xinyi, et al.
Publicado: (2020)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease
por: Jaing, Tang-Her, et al.
Publicado: (2023)

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
por: Zhao, Lu, et al.
Publicado: (2019)

CCR7 Expressing Mesenchymal Stem Cells Potently Inhibit Graft-versus-Host Disease by Spoiling the Fourth Supplemental Billingham’s Tenet
por: Li, Hong, et al.
Publicado: (2014)

New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
por: Saidu, Nathaniel Edward Bennett, et al.
Publicado: (2020)

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021)

Mesenchymal Stem Cell Therapy Overcomes Steroid Resistance in Severe Gastrointestinal Acute Graft-Versus-Host Disease
por: Moritani, Kyoko, et al.
Publicado: (2019)

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
por: Murata, Makoto, et al.
Publicado: (2021)

Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
por: Zhou, Xueke, et al.
Publicado: (2020)

Current Status and Perspectives of Human Mesenchymal Stem Cell Therapy
por: Choi, Jane Ru, et al.
Publicado: (2019)

NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme
por: Zhang, Ping, et al.
Publicado: (2019)

Adult human mesenchymal stromal cells and the treatment of graft versus host disease
por: Herrmann, Richard P, et al.
Publicado: (2014)

Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
por: Dunavin, Neil, et al.
Publicado: (2017)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020)

Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019)

Role of abatacept in the prevention of graft-versus-host disease: current perspectives
por: Ngwube, Alexander, et al.
Publicado: (2023)

Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease
por: Yoo, Hyun Seung, et al.
Publicado: (2013)

B Lymphocytes Are the Target of Mesenchymal Stem Cells Immunoregulatory Effect in a Murine Graft-versus-Host Disease Model
por: Lu, Di, et al.
Publicado: (2019)

Corneal perforation associated with ocular graft-versus-host disease
por: Xu, Yue, et al.
Publicado: (2022)

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults
por: Tegla, Cosmin, et al.
Publicado: (2020)

Current Status and Perspectives of Human Mesenchymal Stem Cell Therapy 2020
por: Choi, Jane Ru, et al.
Publicado: (2022)

Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease
por: Kim, Kyoung-Woon, et al.
Publicado: (2015)

Erratum: Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease
por: Yoo, Hyun Seung, et al.
Publicado: (2014)

Small‐sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft‐versus‐host disease
por: Lim, Jisun, et al.
Publicado: (2021)

Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation
por: Tago, Yoshiyuki, et al.
Publicado: (2021)

P1259: HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS AMELIORATE ACUTE GRAFT VERSUS HOST DISEASE BY ELEVATING PHYTOSPHINGOSINE
por: Yang, Guancui, et al.
Publicado: (2023)

Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations
por: Nassiri, Nariman, et al.
Publicado: (2013)

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives
por: Toubai, Tomomi, et al.
Publicado: (2016)

Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
por: Chen, Xiaomei, et al.
Publicado: (2015)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells
por: Liu, Weijiang, et al.
Publicado: (2021)

Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway
por: Lim, Jisun, et al.
Publicado: (2020)

Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease
por: Lin, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g39c0g6c8u9qcki43mntd3q627